Hemostemix Inc. (HMTXF)

USD 0.05

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 223.00 495.00 1101.00 2448.00 1688.00 -
Gross Profit -223.00 -495.00 -1101.00 -2448.00 -1688.00 -
Operating Expenses 2.33 Million 4.57 Million 6.65 Million 7.46 Million 4.69 Million 6.42 Million
Selling, General and Administrative Expenses 1.94 Million 3.95 Million 6.47 Million 6.81 Million 2.34 Million 4.15 Million
Research and Development Expenses 384.88 Thousand 622.65 Thousand 179.9 Thousand 650.05 Thousand 2.35 Million 2.26 Million
Other Expenses - - - - - -
Cost and Expenses 2.33 Million 4.57 Million 6.65 Million 7.46 Million 4.69 Million 6.42 Million
Operating Income -2.33 Million -4.58 Million -6.66 Million -7.47 Million -4.69 Million -6.64 Million
Interest Expense - 350.31 Thousand 10.48 Thousand 106.04 Thousand 104.98 Thousand -
Income Tax Expense - 486.92 Thousand -255.78 Thousand 106.04 Thousand 104.98 Thousand 6222.00
Earnings before Tax -2.5 Million -4.74 Million -6.54 Million -7.76 Million -4.86 Million -6.18 Million
Net Income -2.5 Million -5.23 Million -6.28 Million -7.76 Million -4.86 Million -6.18 Million
Earnings Per Share Basic -0.03 -0.07 -0.11 -0.24 -0.32 -0.41
Earnings Per Share Diluted -0.03 -0.07 -0.11 -0.24 -0.32 -0.41
Weighted Average Shares Outstanding 82.5 Million 69.98 Million 57.44 Million 32.24 Million 15.04 Million 14.93 Million
Weighted Average Shares Outstanding (Diluted) 82.49 Million 69.98 Million 57.44 Million 32.24 Million 15.04 Million 14.93 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -2.33 Million -4.58 Million -2.76 Million -7.47 Million -4.69 Million -
Earnings Before Tax Margin - - - - - -

Income Statement Charts